The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-(3-(4-(7-methoxy-1H-indol-2-yl)-5-methyl-6-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-2-yl)benzyl)-N2-methylethane-1,2-diamine ID: ALA5278488
Max Phase: Preclinical
Molecular Formula: C29H36N6O2
Molecular Weight: 500.65
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNCCNCc1cccc(-c2nc(NC3CCOCC3)c(C)c(-c3cc4cccc(OC)c4[nH]3)n2)c1
Standard InChI: InChI=1S/C29H36N6O2/c1-19-26(24-17-21-7-5-9-25(36-3)27(21)33-24)34-29(35-28(19)32-23-10-14-37-15-11-23)22-8-4-6-20(16-22)18-31-13-12-30-2/h4-9,16-17,23,30-31,33H,10-15,18H2,1-3H3,(H,32,34,35)
Standard InChI Key: XOXPZSODYFVICP-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
6.6888 -27.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6877 -28.2614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3957 -28.6704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1054 -28.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1026 -27.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3939 -27.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9810 -27.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2734 -27.4422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8087 -27.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5152 -27.4360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2209 -27.0254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2183 -26.2073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5040 -25.8016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8013 -26.2145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9239 -25.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4981 -24.9844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7874 -24.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7840 -23.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0774 -23.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3703 -23.7689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3743 -24.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0854 -24.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9275 -27.4295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5656 -27.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8580 -27.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1502 -27.0342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4426 -27.4429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0200 -28.2352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6738 -27.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2210 -27.6946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8159 -28.3966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2212 -29.0963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0315 -29.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4347 -28.3887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0271 -27.6918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8136 -29.8046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9964 -29.8057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
5 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
13 16 1 0
16 17 1 0
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
11 23 1 0
8 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
23 28 1 0
28 31 1 0
30 29 1 0
29 23 2 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
32 36 1 0
36 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 500.65Molecular Weight (Monoisotopic): 500.2900AlogP: 4.51#Rotatable Bonds: 10Polar Surface Area: 96.12Molecular Species: BASEHBA: 7HBD: 4#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.04CX Basic pKa: 9.60CX LogP: 3.95CX LogD: 1.75Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.24Np Likeness Score: -0.65
References 1. Zhang Z, Guo Z, Xu X, Cao D, Yang H, Li Y, Shi Q, Du Z, Guo X, Wang X, Chen D, Zhang Y, Chen L, Zhou K, Li J, Geng M, Huang X, Xiong B.. (2021) Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy., 64 (22.0): [PMID:34781683 ] [10.1021/acs.jmedchem.1c01308 ]